Skip to content

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Application of Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05813379
Enrollment
20
Registered
2023-04-14
Start date
2022-02-01
Completion date
2023-08-30
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti Aging

Keywords

Anti aging, Rejuvenation, Repair, Regeneration

Brief summary

Aging is a natural and complex process. The effect of environmental factors, genetics on the body eventually leads to damage in different ways. Exosomes are present in almost all body fluids, such as synovial fluid and blood. Exosomes and microvesicles are very efficient mediators of cell-to-cell communication by transferring their specific cargo to recipient cells; for example, exosomes are involved in the delivery of genetic materials, causing epigenetic modifications in the target cells .The applications of MSC-derived exosomes have more effect in cutaneous regeneration by collagen stimulation.The basic biology of exosomes indicates that MSC-exosomes may contain MSC-specific components to exert specific effects on recipient cells, which are somewhat equivalent to the regenerative effects of MSCs. This study aims to slow down the aging process of the skin by using exosome.

Detailed description

Skin aging is a complex biological process that can be classified into extrinsic or intrinsic aging. Intrinsic aging is an intrinsic degradation process that is caused by a decrease in the proliferation capacity leading to cell senescence. Angiogenesis is essential in various physiological processes, including wound healing and skin tissue regeneration. Literature reviews show that exosomes derived from human umbilical cord blood mesenchymal stem cells can cause Collagen stimulation and reduction of oxidative stress, WNT/βcatenin pathway signaling in the initial stages of causes the regeneration of skin damage . This study aims to slow down the aging process of the skin by using exosome.

Interventions

COMBINATION_PRODUCTexosime injection

Treatment- exosome injection

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* females * Ages 35-65 * Patients of all racial and ethnic origins * Patients of all undergoing facial rejuvenation

Exclusion criteria

* Female patients in pregnancy or menstrual period * Patients undergoing facial rejuvenation using other methods including Botox injections, chemical peels, face lifts and others * Patients using blood thinners, aspirin and hormone, that cannot be stopped * Patients suffering with severe organic disease, such as coronary heart disease, hypertension, diabetes, lung dysfunction and so on * Patients suffering with mental disease, and acute or chronic infectious diseases

Design outcomes

Primary

MeasureTime frameDescription
Proportion of re-epithelialization1 monthIn order to evaluate the treatment effect, to evaluate wrinkles and collagen before the treatment, take a photo/CT of the face

Countries

Iran

Contacts

Primary ContactLeila Dehghani, Dr
l_dehghani2002@yahoo.com+983136201250

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026